inzulinterápiával

Inzulinterápia, often translated as insulin therapy, is a cornerstone treatment for diabetes mellitus, a chronic condition characterized by high blood glucose levels. It involves administering exogenous insulin to regulate blood sugar when the body's own insulin production is insufficient or ineffective. This therapy is essential for individuals with type 1 diabetes, where the pancreas produces little to no insulin, and is also used for some individuals with type 2 diabetes, especially as the disease progresses.

The primary goal of inzulinterápia is to maintain blood glucose levels within a target range to prevent both short-term complications like hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar), and long-term complications such as damage to the eyes, kidneys, nerves, and cardiovascular system. Insulin is typically administered via subcutaneous injection using syringes, insulin pens, or insulin pumps. The type of insulin used, the dosage, and the timing of administration are carefully individualized based on a person's blood glucose monitoring results, diet, activity level, and other factors. Regular monitoring of blood glucose is crucial for effective management and adjustment of insulin therapy.